bovin
respiratori
diseas
brd
complex
common
extens
studi
cattl
diseas
age
especi
feedlot
cattl
veal
calv
brd
repres
major
indic
cattl
antimicrobi
worldwid
especi
prophylaxi
metaphylaxi
coupl
mortal
treatment
cost
decreas
perform
reduc
carcass
valu
brd
lead
major
econom
loss
cattl
feeder
ive
richeson
complex
viral
bacteri
andor
mycoplasm
infect
describ
blanket
term
enzoot
pneumonia
ship
fever
bovin
respiratori
diseas
complex
often
use
without
precis
definit
virus
stressor
predispos
cattl
opportunist
bacteri
pneumonia
includ
bovin
respiratori
syncyti
viru
infecti
bovin
rhinotrach
viru
bovin
herp
possibl
bovin
coronaviru
neill
et
virus
trigger
brd
damag
upper
respiratori
tract
mucosa
andor
modifi
host
pro
antiinflammatori
immun
respons
bacteri
brd
pathogen
includ
mannheimia
haemolytica
pasteurella
multocida
histophilu
somni
arcanobacterium
pyogen
mycoplasma
dispar
bovi
exist
commonli
commens
often
biofilm
within
upper
respiratori
tract
tonsil
classic
brd
field
diagnosi
visual
sign
includ
depress
anorexia
nasal
andor
ocular
discharg
cough
labour
breath
buhman
et
semiobject
fourpoint
clinic
ill
score
perino
apley
subject
nonstandardis
typic
basi
decid
antimicrobi
treatment
combin
rectal
temperatur
although
bovin
fever
threshold
vari
throughout
scientif
literatur
ive
richeson
compar
brd
field
diagnost
pulmonari
lesion
evid
slaughter
reveal
sever
cattl
eg
lung
lesion
previous
identifi
treat
brd
thompson
stone
schultheiss
tennant
et
limit
contribut
larg
justif
routin
antimicrobi
prophylaxismetaphylaxi
place
identifi
pull
treat
sick
calvescattl
culmin
stressor
eg
recent
wean
auction
transport
environmentalnutrit
chang
comingl
castrat
result
cohort
feedlot
cattlev
calv
express
major
visual
brd
case
within
first
day
arriv
edward
buhman
et
soon
introduct
antimicrobi
agent
growthpromot
effect
discov
anim
moor
et
antimicrobi
approv
growth
promot
usa
sinc
sinc
uk
swann
howev
mount
evid
antimicrobi
resist
transfer
resist
gene
anim
human
microbiota
led
full
withdraw
antimicrobi
growth
promot
european
union
sinc
regul
european
support
recommend
world
health
organ
food
agricultur
organ
fao
world
organ
anim
health
ban
antimicrobi
growth
promot
encourag
countri
follow
eg
canada
usa
south
korea
sinc
ban
antimicrobi
mass
medic
purpos
diseas
prevent
becom
common
use
healthi
food
anim
differ
term
describ
mass
medic
concept
food
anim
prophylaxi
prevent
metaphylaxi
antimicrobi
prophylaxi
brd
first
appear
scientif
literatur
king
et
metaphylaxi
appear
later
concept
believ
still
heavili
use
exact
consumpt
figur
food
anim
antimicrobi
mass
medic
larg
unknown
variou
definit
describ
prophylaxi
prevent
metaphylaxi
prophylaxi
prevent
defin
similarli
administr
veterinari
medicin
product
vmp
healthi
anim
prevent
infect
base
risk
possibl
consequ
ecdcefsaema
ema
typic
risk
neither
clearli
defin
quantifi
common
reason
includ
previou
histori
herd
outbreakstradit
herd
manag
practic
attitud
introduct
new
anim
group
eg
welcom
shot
high
stock
densiti
ie
increas
risk
diseas
schedul
event
product
anim
cycl
eg
dryoff
cow
period
transport
stress
event
eg
wean
parturit
castrat
dehorn
diet
qualiti
problem
diet
changesintercurr
viral
protozo
diseas
origin
metaphylaxi
defin
prophylaxi
differ
prophylaxi
appli
individu
metaphylaxi
whole
groupsflocksherd
urbanchmiel
groom
other
redefin
metaphylaxi
mass
medic
healthi
anim
diseas
interest
present
within
groupflockherd
ema
other
defin
metaphylaxi
indic
highrisk
individu
number
clinic
case
within
group
reach
threshold
remaind
incontact
anim
treat
simultan
order
restrict
spread
impact
diseas
lee
shojae
aliabadi
accord
edward
smith
et
al
criterion
antimicrobi
metaphylaxi
occur
morbid
ie
attack
rate
exce
two
three
consecut
day
thu
prophylaxisprevent
metaphylaxi
involv
administ
antimicrobi
healthi
individu
prevent
infect
prophylaxisprevent
perceiv
risk
wherea
metaphylaxi
could
defin
hazard
routin
antimicrobi
prophylaxismetaphylaxi
uniqu
veterinari
concept
sinc
equival
modern
exampl
human
medicin
routin
antimicrobi
mass
medic
healthi
individu
would
difficult
specifi
routin
prophylaxismetaphylaxi
lead
substanti
antimicrobi
consumpt
sinc
healthi
individu
alway
outnumb
sick
individu
except
situat
mani
food
anim
antimicrobi
vmp
formul
design
easi
mass
medic
dissemin
either
bulk
anim
feed
common
drink
water
sinc
consid
inconveni
impract
separ
diseas
healthi
anim
intens
livestock
product
condit
routin
prophylaxismetaphylaxi
employ
commonli
even
unintend
exampl
assum
antimicrobi
vmp
dissemin
either
bulk
anim
feed
drink
water
prefer
prophylaxismetaphylaxi
eg
premix
oral
powdersgranulessolut
drink
water
european
data
countri
overal
sale
tonn
activ
ingredi
antimicrobi
reveal
antimicrobi
sale
report
mgpcu
popul
correct
unit
tonn
estim
weight
treatment
livestock
slaughter
anim
vmp
formul
esvac
furthermor
inject
antimicrobi
also
use
prophylaxismetaphylaxi
food
anim
evidencebas
recommend
food
anim
antimicrobi
mass
medic
spars
mostli
embodi
antithesi
prudent
use
odd
plea
unit
nation
fao
oie
call
ration
antimicrobi
use
food
anim
need
antimicrobi
mass
medic
base
belief
group
anim
especi
newli
receiv
stress
contract
major
bacteri
diseas
ie
morbid
andor
die
ie
mortal
result
econom
welfar
consequ
ancillari
benefit
better
averag
daili
weight
gain
ie
growth
promot
belief
less
antimicrobi
treatment
requir
later
product
cycl
ie
reduc
labour
cost
given
grow
recognit
one
health
agenda
anim
human
system
connect
relev
better
understandquest
origin
scientif
evid
antimicrobi
prophylaxismetaphylaxi
food
anim
reduc
morbid
mortal
bacteri
diseas
beef
product
feedlot
veal
one
world
largest
food
anim
industri
thu
appropri
choic
investig
antimicrobi
prophylaxismetaphylaxi
object
perform
systemat
review
metaanalysi
randomis
control
clinic
trial
rct
investig
antimicrobi
prophylaxi
andor
metaphylaxi
prevent
natur
occur
brd
primari
object
assess
rct
investig
brd
antimicrobi
prophylaxismetaphylaxi
impact
prevent
morbid
secondari
object
assess
rct
investig
brd
antimicrobi
prophylaxismetaphylaxi
impact
prevent
mortal
object
assess
characterist
antimicrobi
eg
type
rout
administr
prevent
brd
morbid
mortal
compar
prophylaxi
metaphylaxi
analysi
morbid
data
perform
random
effect
model
r
packag
metafor
viechtbauer
use
restrict
maximum
likelihood
method
estim
true
betweenstudi
varianc
heterogen
studi
identifi
statist
due
heterogen
studi
summari
effect
measur
casu
rel
riskrr
calcul
use
random
effect
metaanalysi
inversevari
weight
potenti
factor
affect
heterogen
analys
random
effect
metaregress
separ
analysi
perform
morbid
mortal
data
respect
data
distribut
rct
assess
funnel
plot
viechtbauer
also
trimandfil
analysi
duval
tweedi
perform
residu
use
trimfil
function
metafor
test
funnel
plot
asymmetri
identifi
miss
studi
analysi
assum
funnel
plot
symmetri
attempt
remov
trim
smaller
studi
associ
asymmetri
fill
distribut
miss
studi
balanc
distribut
rct
morbid
data
assess
use
number
need
treat
nnt
absolut
risk
reduct
arr
calcul
expect
relat
nnt
attack
rate
cer
follow
express
use
fig
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
upgreek
usepackag
mathrsf
setlength
oddsidemargin
begin
document
begin
eqnarray
rm
arr
rm
cer
rm
eer
rm
cer
rm
rr
time
rm
cer
hbox
hphantom
mmmmmm
rm
nnt
rm
arr
rm
nnt
frac
rm
arr
frac
rm
cer
rm
rr
rm
cer
frac
rm
cer
left
rm
rr
right
end
eqnarray
end
document
cer
control
group
event
rate
eer
experiment
group
event
rate
rr
rel
risk
estim
mortal
data
differ
morbid
data
studi
show
low
mortal
rate
sever
zeroev
cell
mortal
control
andor
treatment
group
therefor
mortal
data
analys
mantelhaenszel
method
calcul
summari
rr
confid
interv
ci
higgin
green
studi
zeroev
valu
ad
cell
zerocel
correct
onlin
search
engin
identifi
sever
public
rang
titlesabstract
total
public
peerreview
intern
confer
sourc
met
criteria
primari
object
summar
individu
rct
publish
scheel
perri
et
janzen
mcmanu
breez
et
lofgreen
peter
albak
bradstock
cruis
gill
et
schumann
janzen
mckinnon
harland
et
schumann
janzen
mckinnon
van
koever
et
hill
gill
ball
morck
et
lauridsen
jorgensen
olsen
mccoy
et
gallo
berg
galyean
gunter
malcolmc
hugh
tice
connor
kreikemei
stokka
marston
brazl
klemesrud
et
mcclari
vogel
mechor
vogel
frank
duff
schmidt
et
frank
et
hibbard
et
kato
et
lechtenberg
hanna
cusack
skogerbo
et
anonym
godinho
et
kilgor
et
encinia
et
bremer
et
et
benton
et
catri
et
coe
et
johnson
et
caluwaert
et
heinrich
et
checkley
et
sgoifo
rossi
et
baggott
et
et
lechtenberg
et
bechtol
et
hendrick
bateman
rosengren
schlegel
et
fazzio
et
stanford
et
dedond
et
sourc
public
includ
proprietari
data
describ
two
freedom
inform
act
summari
rct
nine
univers
research
progress
report
rct
four
pharmaceut
compani
technic
bulletin
rct
prophylaxi
rct
includ
public
rct
intern
rct
rct
fig
metaphylaxi
rct
includ
public
rct
intern
rct
rct
fig
two
public
assess
prophylaxi
metaphylaxi
rct
feedlot
describ
public
rct
four
concern
vealdairi
calv
rct
two
cowcalf
oper
rct
one
bulltest
station
rct
observ
period
rct
rang
day
rct
rct
rct
rct
major
public
describ
uniform
process
cattlecalv
upon
arriv
test
facil
includ
inject
varieti
vaccin
vitamin
product
deworm
occasion
product
eg
growth
implant
afterward
cattl
separ
treatment
control
group
consid
typic
field
condit
introduct
calv
feedlot
veal
calf
oper
clinic
trial
describ
antimicrobi
use
accord
label
dose
rct
rct
minor
label
dose
rct
rct
label
dose
rct
rct
thirteen
brd
public
describ
initi
treatment
neg
control
salin
use
rout
administr
treatment
group
rct
one
placebo
oral
bolu
rct
one
formul
treatment
group
minu
antimicrobi
substanc
rct
public
placebo
treatment
control
group
rct
major
rct
describ
two
visual
clinic
sign
brd
assess
eg
depress
poor
bodi
condit
anorexia
abnorm
respir
cough
oculonas
discharg
rct
also
includ
presenc
fever
assess
descript
state
rct
method
randomis
describ
includ
public
rct
rct
randomblock
design
public
rct
rct
systemat
randomis
public
rct
rct
describ
computerstatist
randomis
public
rct
descript
also
public
rct
rct
utilis
blind
studi
design
public
rct
rct
describ
person
give
treatment
blind
public
rct
rct
describ
person
check
cattlepen
brd
blind
mani
rct
demonstr
benefit
rr
reduc
morbid
either
antimicrobi
prophylaxi
metaphylaxi
fig
although
result
vari
consider
studi
combin
rr
estim
prophylaxi
metaphylaxi
ci
data
asymmetri
identifi
funnel
plot
fig
use
duval
tweedi
trim
fill
method
adjust
combin
rr
estim
funnel
plot
asymmetri
evid
rct
describ
metaphylaxi
particularli
lack
small
studi
report
poor
efficaci
fig
initi
metaphylaxi
rct
rr
ci
perform
significantli
better
p
reduc
brd
morbid
prophylaxi
rr
ci
howev
adjust
rr
estim
reveal
two
type
mass
medic
perform
equal
metaphylaxi
rr
ci
prophylaxi
rr
ci
rct
use
parenter
antimicrobi
subcutan
intramuscular
alon
combin
oral
administr
perform
significantli
better
lower
morbid
compar
oral
administr
alon
ie
rr
ci
versu
rr
ci
p
blind
rct
demonstr
significantli
differ
result
p
nonblind
rct
blindedrr
ci
nonblindedrr
ci
prophylaxi
rct
macrolid
perform
best
reduc
brd
morbid
rr
ci
rct
compar
tetracyclin
rr
ci
rct
tetracyclin
combin
rr
ci
rct
amphenicol
rr
ci
rct
cephalosporin
rr
ci
rct
sulfonamid
rr
ci
rct
fluoroquinolon
rr
ci
rct
fig
metaphylaxi
rct
signific
differ
detect
antimicrobi
class
p
metaphylaxi
definit
includ
public
rct
defin
brd
morbid
within
group
public
rct
defin
pyrexia
symptom
public
rct
cattl
incontact
within
group
visual
brd
cattl
metaphylaxi
definit
demonstr
significantli
differ
result
best
result
brd
morbid
obtain
morbid
definit
rr
ci
compar
incontact
definit
rr
ci
p
fever
definit
rr
ci
p
fig
major
rct
prophylaxismetaphylaxi
fit
correl
decreas
nnt
increas
control
group
attack
rate
fig
nnt
rct
drop
nnt
median
attack
rate
observ
period
durat
rct
affect
morbid
outcom
short
rct
daysrr
ci
demonstr
significantli
better
p
outcom
compar
longer
rct
daysrr
ci
daysrr
ci
daysrr
ci
best
arr
result
brd
morbid
cluster
short
rct
durat
eg
day
fig
also
best
arr
result
brd
morbid
featur
small
rather
larger
rct
public
describ
uniformli
identifi
brd
cattl
pull
pen
treat
prespecifi
treatment
protocol
studi
return
thu
mortal
data
confound
sinc
brd
cattl
ie
treatment
control
group
treat
antimicrobi
record
morbid
data
nevertheless
mortal
data
analys
sinc
repres
treatmentonli
strategi
without
prior
mass
medic
eg
control
group
compar
treatment
strategi
prior
mass
medic
eg
treatment
group
origin
public
accept
morbid
data
analysi
public
rct
rct
contain
suffici
mortal
data
brd
mortal
rate
low
prophylaxi
rct
metaphylaxi
rct
report
zero
mortal
control
group
highest
mortal
rate
fig
antimicrobi
mass
medic
prophylaxi
metaphylaxi
led
rel
reduct
mortal
risk
rr
ci
correl
control
group
result
rr
declin
increas
mortal
rate
subgroup
analysi
reveal
rel
risk
reduct
control
group
mortal
rr
ci
compar
rr
ci
howev
major
rct
demonstr
minor
effect
arr
eg
fig
author
knowledg
first
critic
apprais
evid
antimicrobi
prophylaxi
metaphylaxi
prevent
diseas
morbid
mortal
major
food
anim
speci
systemat
review
metaanalysi
rct
concern
antimicrobi
mass
medic
prevent
brd
identifi
advantag
disadvantag
prophylaxi
metaphylaxi
demonstr
moder
yet
highli
variabl
rel
risk
reduct
brd
morbid
adjust
combin
rr
brd
morbid
reduct
depend
antimicrobi
class
use
fig
metaphylaxi
definit
criteria
fig
brd
attack
rate
fig
durat
rct
fig
disadvantag
includ
best
posit
rr
result
achiev
antimicrobi
class
eg
macrolid
consid
broadspectrum
critic
import
antimicrobi
cia
human
veterinari
medicin
combin
antimicrobi
fig
also
nnt
prevent
one
brd
case
high
circumst
low
attack
rate
variabl
infect
pressur
high
medic
prevent
brd
transmiss
fig
aetiolog
brd
outbreak
found
physiolog
manag
environment
factor
conjunct
viral
bacteri
infecti
agent
genet
select
result
domest
cattl
small
lung
rel
metabol
demand
contribut
decreas
respiratori
compens
particularli
period
exert
diseas
weekli
veit
gener
highrisk
calvescattl
typic
lightweight
recent
wean
highli
comingl
auction
market
origin
extend
transport
time
unknown
healthvaccin
histori
despit
widespread
use
vaccin
antimicrobi
mass
medic
sober
pictur
suggest
limit
progress
north
america
reduc
impact
brd
last
year
hilton
nation
anim
health
monitor
system
data
show
increas
brd
feedlot
mortal
despit
treat
brd
receiv
prophylact
antimicrobi
arriv
dairi
heifer
rear
data
show
prewean
dairi
heifer
treat
brd
includ
brd
mortal
dargatz
data
reveal
feedlot
mortal
increas
per
year
last
year
engler
reaction
increas
relianc
antimicrobi
prophylaxi
andor
metaphylaxi
control
brd
need
mass
medic
driven
antiqu
structur
feedlot
veal
calf
industri
compar
diseas
major
obstacl
control
brd
remain
segment
infrastructur
industri
rel
unchang
sever
decad
ive
richeson
calvescattl
progress
product
phase
chang
ownership
point
result
transport
comingl
variou
sourc
minim
biosecur
stressor
provid
ampl
opportun
immunosuppress
pathogen
colonis
lower
respiratori
tract
estim
averag
number
middl
men
cattl
rancher
consum
ive
richeson
cattl
transport
two
five
time
throughout
lifetim
result
degre
dehydr
physiolog
stress
environmentalnutrit
chang
persist
infrastructur
also
imped
altern
antimicrobi
mass
medic
sinc
major
brd
predisposit
factor
present
time
arriv
facil
brd
field
diagnosi
major
limit
accur
identifi
brd
cattl
common
clinic
sign
eg
depress
anorexia
fever
pathognomon
recent
publish
studi
use
hierarch
bayesian
latent
class
metaanalysi
compar
brd
clinic
sign
slaughter
lung
lesion
reveal
estim
predict
diagnost
sensit
specif
ci
respect
timsit
et
much
variabl
studi
due
differ
criteria
visual
brd
diagnosi
variabl
influenc
number
cattl
manag
per
employe
larg
facil
exampl
report
averag
number
cattl
high
risk
develop
brd
manag
per
employe
feedlot
increas
head
usa
canada
lee
et
relev
rct
systemat
review
metaanalysi
also
reflect
decisionmak
criteria
produc
sinc
everi
identifi
brd
case
treat
antimicrobi
base
nnt
fig
antimicrobi
mass
medic
minor
effect
either
reduc
brd
morbid
risk
affect
decisionmak
process
use
treatment
antimicrobi
exampl
nnt
median
approxim
reduct
arr
pharmacoeconom
benefit
occur
high
attack
rate
eg
benefit
also
variabl
rct
concern
express
previous
qualiti
rct
brd
primarili
treatment
trial
connor
et
consensu
statement
exist
design
specif
clinic
trial
eg
standard
report
trial
reflect
statement
livestock
clinic
trial
publish
connor
et
gener
veterinari
rct
lag
behind
human
rct
quantiti
qualiti
studi
design
featur
eg
blind
descript
randomis
salinetr
placebo
limit
found
investig
includ
lack
rct
certain
antimicrobi
class
metaphylaxi
definit
certain
type
beef
product
system
underrepres
eg
veal
calv
also
type
noncia
repres
rct
longterm
studi
could
better
confirm
declin
benefit
initi
antimicrobi
mass
medic
signific
explanatori
variabl
identifi
heterogen
remain
high
model
due
divers
issu
explor
also
heterogen
reflect
lack
foresight
old
fashion
practic
antimicrobi
mass
medic
base
belief
nonstandardis
risk
without
knowledg
type
pathogen
involv
antimicrobi
suscept
like
food
anim
diseas
brd
diseas
complex
encompass
multipl
pathogen
combin
lack
foresight
thu
attract
broadspectrum
antimicrobi
success
prevent
result
could
view
gener
observ
antimicrobi
mass
medic
field
condit
describ
cohort
food
anim
similar
circumst
eg
transport
comingl
minim
biosecur
broad
diseas
definit
aspect
result
could
fit
concept
express
mathemat
model
infecti
diseas
transmiss
brd
demonstr
diseas
pattern
low
high
morbid
consist
low
mortal
eventu
satur
result
declin
number
suscept
individu
infect
occur
time
day
brd
stabl
popul
dynam
grassli
fraser
broad
rang
attack
rate
rct
reflect
field
variat
infecti
characterist
infect
individu
determin
rate
spread
suscept
popul
broken
biolog
behaviour
environment
compon
suscept
biolog
behaviour
environment
cohort
cattl
exampl
low
attack
rate
basic
reproduct
number
ro
expect
number
secondari
infect
result
infect
individu
popul
mathemat
model
typic
incorpor
variabl
describ
probabl
transmiss
per
anim
contact
number
contact
infecti
anim
per
unit
time
durat
anim
infecti
suffici
low
base
small
offspr
distribut
number
secondari
infect
function
infecti
time
econom
justifi
prior
antimicrobi
mass
medic
base
nnt
circumst
diseas
could
die
ro
becom
endem
ro
unlik
progress
epidem
ro
morbid
threshold
exist
antimicrobi
mass
medic
provid
consist
reduct
morbid
risk
fig
neglig
effect
mortal
fig
broadli
consist
gener
observ
disproportion
amount
diseas
transmiss
result
small
fraction
infect
individu
grassli
fraser
random
effect
among
individu
tend
cancel
number
infect
individu
increas
result
predict
progress
epidem
dynam
antimicrobi
mass
medic
repres
main
intervent
brd
ie
ro
preventcontrol
epidem
result
investig
reveal
impact
intervent
influenc
durat
rct
exampl
highest
impact
cluster
short
small
rct
day
fig
progress
less
impact
longer
larger
rct
longer
rct
better
reflect
feedlotv
facil
sinc
cattl
typic
kept
month
also
high
variabl
antimicrobi
intervent
reflect
complex
brd
infecti
diseas
dynam
likelihood
three
possibl
outcom
popul
scenario
endem
epidem
diseas
die
depend
factor
includ
herd
signific
proport
popul
immun
eg
vaccin
natur
acquir
colostr
immun
thu
difficult
diseas
spread
individu
proport
alreadi
immun
break
chain
infect
anim
stress
factor
promot
immunosuppress
eg
wean
castrat
dehorn
anim
husbandri
practic
promot
contagi
diseas
eg
stock
densiti
transport
anim
comingl
anim
differ
sourc
poor
biosecur
characterist
bacteri
clone
involv
diseas
eg
virul
factor
antigen
previou
exposur
popul
although
rct
result
brd
mortal
confound
previou
treatment
brd
cattl
reveal
interest
aspect
major
rct
report
zero
mortal
control
group
base
treatmentonli
strategi
visual
brd
case
prior
mass
medic
effect
method
prevent
mortal
prudent
use
antimicrobi
judici
practic
medic
principl
costeffect
use
antimicrobi
maximis
clinic
therapeut
effect
minim
drugrel
toxic
develop
antimicrobi
resist
includ
accur
diagnosi
shortterm
effect
first
antimicrobi
profession
prescript
base
microbi
sensit
proven
efficaci
rct
safeti
pkpd
spectrum
activ
low
impact
select
antimicrobialresist
bacteria
brd
antimicrobi
mass
medic
fail
aspect
prudent
use
diseas
prevent
poorli
distinguish
primari
viral
case
lung
lesion
without
knowledg
incit
pathogen
microbi
sensit
systemat
review
metaanalysi
rct
reveal
antimicrobi
mass
medic
lead
mean
overal
rel
reduct
diseas
burden
econom
lower
absolut
risk
either
display
visual
brd
symptom
select
antimicrobi
treatment
best
rel
risk
reduct
primarili
broadspectrum
critic
import
antimicrobi
class
metaphylaxi
similar
impact
prophylaxi
potenti
lower
antimicrobi
consumpt
appropri
morbid
threshold
definit
elimin
least
effici
highest
nnt
possibl
prevent
epidem
prophylaxismetaphylaxi
brd
repres
major
antimicrobi
consumpt
highli
variabl
shortterm
gain
arr
wherea
rct
longer
durat
eg
day
show
progress
dampen
variabl
arr
antimicrobi
mass
medic
also
associ
neglig
improv
worsen
brd
morbiditymort
conflict
interest
none
declar
